Lunai Bioworks Inc.
LNAI | NASDAQ
$2.30
-$0.03 (-1.29%)
At close: Sep 21, 2026, 4:00 PM ET
$2.12
-$0.18 (-7.83%)
Pre-market:
Sep 22, 2026, 4:48 AM ET
Fiscal Year Period Ending | FY 2024 Jun 29, 2025 | FY 2023 Jun 29, 2024 | FY 2022 Jun 29, 2023 | FY 2021 Jun 29, 2022 | FY 2020 Jun 29, 2021 |
|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 129.09K | n/a | n/a | n/a | 391.42K |
Gross Profit | -129.09K | n/a | n/a | n/a | -391.42K |
Operating Income | -18.55M | -81.64M | -38.56M | -116.08M | -23.4M |
Interest Income | 116.35K | n/a | n/a | 122.04K | 13.18K |
Pretax Income | -178.01M | -88.43M | -39.68M | -113.43M | -26.85M |
Net Income | -178.01M | -88.43M | -39.68M | -113.43M | -26.72M |
Selling & General & Admin | 17.88M | 24.56M | 15.32M | 14.33M | 7.47M |
Research & Development | 537.43K | 2.71M | 4.17M | 8.37M | 15.54M |
Other Expenses | n/a | 54.37M | 19.07M | 93.38M | n/a |
Operating Expenses | 18.42M | 81.64M | 38.56M | 116.08M | 23.01M |
Interest Expense | 725.68K | 2.43M | 706.96K | 372.84K | 379.61K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.55M | 81.64M | 38.56M | 116.08M | 23.4M |
Income Tax Expense | n/a | n/a | n/a | 34 | -125.28K |
Shares Outstanding (Basic) | 2.06M | 1.22M | 703.32K | 656.6K | 589.59K |
Shares Outstanding (Diluted) | 2.06M | 1.22M | 703.32K | 656.6K | 589.59K |
EPS (Basic) | -86.24 | -72.80 | -56.80 | -172.80 | -45.36 |
EPS (Diluted) | -86.24 | -72.80 | -56.80 | -172.80 | -45.36 |
EBITDA | -18.42M | -85.87M | -38.86M | -112.94M | -26.08M |
EBIT | -18.55M | -85.99M | -38.98M | -113.06M | -26.47M |
Depreciation & Amortization | 129.1K | 121.86K | 113.5K | 123.59K | 391.42K |
Add to Watchlist
Select watchlists to add or remove LNAI